Medtronic To Pay $22M To Resolve Some Bone Graft Suits
Medtronic Inc. has agreed to pay $22 million to settle some product liability suits over its Infuse product, a bone graft substitute that patients across the country claim Medtronic promoted for...To view the full article, register now.
Already a subscriber? Click here to view full article